Study of Ravulizumab in Pediatric Participants With Primary IgAN | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Ravulizumab in Pediatric Participants With Primary IgAN	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Hemorrhage, IgA glomerulonephritis, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Urination Disorders, Urogenital Diseases, Urological Manifestations, autoimmune disease, blood coagulation disease, cardiovascular disorder, glomerulonephritis, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, kidney disorder, nephritis, proteinuria, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, urinary system disorder, vascular disorder, vascular hemostatic disease, vasculitis	Recruiting	Phase 3	2026-07-30		NCT07024563

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alexion Pharmaceuticals, Inc.	48

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.